Calyxt Stock Price, News & Analysis (NASDAQ:CLXT)

$19.81 -2.40 (-10.81 %)
(As of 02/21/2018 06:24 AM ET)
Previous Close$22.21
Today's Range$19.77 - $22.05
52-Week Range$9.26 - $31.89
Volume58,900 shs
Average Volume51,421 shs
Market Capitalization$615.06 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Calyxt (NASDAQ:CLXT)

Calyxt logoCalyxt, Inc. is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics. The Company products include Consumer Centric and Farmer Centric products. Consumer Centric product, which includes high oleic soybean, high fiber wheat, high fiber wheat II, reduced gluten wheat, cold storable potato and reduced browning potato. Farmer Centric products, which includes drought tolerant soybean, improved soybean, herbicide tolerant wheat, herbicide tolerant canola, herbicide tolerant alfalfa and herbicide quality alfalfa.The Company has several products under development including high oleic soybeans, powdery mildew resistant wheat and cold storable potato.

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural Biotechnology
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:CLXT
CUSIPN/A
Phone651-683-2807

Debt

Debt-to-Equity Ratio0.13%
Current Ratio12.41%
Quick Ratio12.41%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$390,000.00
Price / Sales1,406.51
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net Income$-12,080,000.00
Net Margins-5,969.52%
Return on Equity-101.69%
Return on Assets-76.32%

Miscellaneous

Employees27
Outstanding Shares27,690,000

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

Where is Calyxt's stock going? Where will Calyxt's stock price be in 2018?

5 brokerages have issued 1-year target prices for Calyxt's shares. Their predictions range from $22.00 to $34.25. On average, they anticipate Calyxt's share price to reach $29.05 in the next year. View Analyst Ratings for Calyxt.

Who are some of Calyxt's key competitors?

Who are Calyxt's key executives?

Calyxt's management team includes the folowing people:

  • Andre Choulika, Chairman of the Board (Age 52)
  • Federico A. Tripodi, Chief Executive Officer (Age 40)
  • Bryan W. J. Corkal, Chief Financial Officer (Age 49)
  • Joseph B Saluri, General Counsel, Executive Vice President – Corporate Development (Age 50)
  • Daniel F. Voytas Ph.D., Chief Scientific Officer (Age 54)
  • Glenn R Bowers Ph.D., Vice President - Breeding (Age 64)
  • Michel Arbadji, Director of Business Development (Age 52)
  • Manoj Sahoo, Chief Commercial Officer (Age 42)
  • Laurent Arthaud, Director (Age 54)
  • Alain Godard, Director (Age 71)

When did Calyxt IPO?

(CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

When did Calyxt's lock-up period expire?

Calyxt's lock-up period expired on Tuesday, January 16th. Calyxt had issued 7,000,000 shares in its public offering on July 20th. The total size of the offering was $56,000,000 based on an initial share price of $8.00. Since the end of Calyxt's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Who owns Calyxt stock?

Calyxt's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (2.67%), Wells Fargo & Company MN (0.11%), Deutsche Bank AG (0.07%), TIAA CREF Investment Management LLC (0.07%), Goldman Sachs Group Inc. (0.05%) and Spark Investment Management LLC (0.04%). View Institutional Ownership Trends for Calyxt.

Who sold Calyxt stock? Who is selling Calyxt stock?

Calyxt's stock was sold by a variety of institutional investors in the last quarter, including TIAA CREF Investment Management LLC and Spark Investment Management LLC. View Insider Buying and Selling for Calyxt.

Who bought Calyxt stock? Who is buying Calyxt stock?

Calyxt's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Wells Fargo & Company MN, Goldman Sachs Group Inc. and Deutsche Bank AG. View Insider Buying and Selling for Calyxt.

How do I buy Calyxt stock?

Shares of Calyxt can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Calyxt's stock price today?

One share of Calyxt stock can currently be purchased for approximately $19.81.

How big of a company is Calyxt?

Calyxt has a market capitalization of $615.06 million and generates $390,000.00 in revenue each year. Calyxt employs 27 workers across the globe.

How can I contact Calyxt?

Calyxt's mailing address is 600 COUNTY ROAD D WEST SUITE 8, NEW BRIGHTON MN, 55112. The company can be reached via phone at 651-683-2807.


MarketBeat Community Rating for Calyxt (CLXT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  163
MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Calyxt (NASDAQ:CLXT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.802.753.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $29.05$29.05$27.75$16.33
Price Target Upside: 37.55% upside37.55% upside54.68% upside33.33% upside

Calyxt (NASDAQ:CLXT) Consensus Price Target History

Price Target History for Calyxt (NASDAQ:CLXT)

Calyxt (NASDAQ:CLXT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/20/2017Ladenburg Thalmann Financial ServicesInitiated CoverageBuy -> Buy$34.25HighView Rating Details
11/16/2017CitigroupLower Price TargetNeutral$27.00 -> $22.00N/AView Rating Details
11/1/2017Jefferies GroupBoost Price TargetBuy$27.00N/AView Rating Details
10/30/2017BMO Capital MarketsInitiated CoverageOutperform$32.00N/AView Rating Details
9/29/2017Wells Fargo & CoBoost Price TargetOutperform$17.00 -> $30.00MediumView Rating Details
(Data available from 2/21/2016 forward)

Earnings

Calyxt (NASDAQ:CLXT) Earnings History and Estimates Chart

Earnings by Quarter for Calyxt (NASDAQ:CLXT)

Calyxt (NASDAQ CLXT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/13/2017Q3 2017($0.16)($0.51)ViewN/AView Earnings Details
9/1/2017Q2 2017($0.11)($0.17)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Calyxt (NASDAQ:CLXT) Earnings Estimates

2018 EPS Consensus Estimate: ($1.16)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.26)($0.26)($0.26)
Q2 20181($0.27)($0.27)($0.27)
Q3 20181($0.32)($0.32)($0.32)
Q4 20181($0.31)($0.31)($0.31)
Q1 20191($0.27)($0.27)($0.27)
Q2 20191($0.28)($0.28)($0.28)
Q3 20191($0.30)($0.30)($0.30)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Calyxt (NASDAQ:CLXT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Calyxt (NASDAQ CLXT) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 22.59%
Insider Trades by Quarter for Calyxt (NASDAQ:CLXT)
Institutional Ownership by Quarter for Calyxt (NASDAQ:CLXT)

Calyxt (NASDAQ CLXT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/25/2017Philippe DumontDirectorBuy400$8.00$3,200.0019,600View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Calyxt (NASDAQ CLXT) News Headlines

Source:
DateHeadline
Calyxt, Inc. (CLXT) Receives Consensus Rating of "Buy" from BrokeragesCalyxt, Inc. (CLXT) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 8 at 1:32 AM
Calyxt, Inc. (CLXT) Given Consensus Recommendation of "Buy" by AnalystsCalyxt, Inc. (CLXT) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - January 14 at 1:32 AM
Calyxt, Inc.s (CLXT) Lock-Up Period Will End  on January 16thCalyxt, Inc.'s (CLXT) Lock-Up Period Will End on January 16th
www.americanbankingnews.com - January 9 at 1:22 AM
Calyxt (CLXT) Stock Rating Upgraded by Zacks Investment ResearchCalyxt (CLXT) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - January 8 at 8:36 PM
Zacks Investment Research Downgrades Calyxt (CLXT) to SellZacks Investment Research Downgrades Calyxt (CLXT) to Sell
www.americanbankingnews.com - January 3 at 12:06 AM
Calyxt IncCalyxt Inc
www.bloomberg.com - December 21 at 8:55 AM
Calyxt, Inc. (CLXT) Given Consensus Rating of "Buy" by AnalystsCalyxt, Inc. (CLXT) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - December 20 at 9:28 AM
Ladenburg Thalmann Financial Services Begins Coverage on Calyxt (CLXT)Ladenburg Thalmann Financial Services Begins Coverage on Calyxt (CLXT)
www.americanbankingnews.com - December 20 at 9:24 AM
Head to Head Survey: Calyxt (CLXT) and Evogene (EVGN)Head to Head Survey: Calyxt (CLXT) and Evogene (EVGN)
www.americanbankingnews.com - December 15 at 7:10 PM
Financial Analysis: Evogene (EVGN) versus Calyxt (CLXT)Financial Analysis: Evogene (EVGN) versus Calyxt (CLXT)
www.americanbankingnews.com - December 14 at 1:28 PM
Financial Analysis: Calyxt (CLXT) vs. Evogene (EVGN)Financial Analysis: Calyxt (CLXT) vs. Evogene (EVGN)
www.americanbankingnews.com - December 13 at 5:38 PM
Contrasting Calyxt (CLXT) and Evogene (EVGN)Contrasting Calyxt (CLXT) and Evogene (EVGN)
www.americanbankingnews.com - December 13 at 5:38 PM
Calyxt (CLXT) vs. Evogene (EVGN) Head-To-Head ReviewCalyxt (CLXT) vs. Evogene (EVGN) Head-To-Head Review
www.americanbankingnews.com - December 13 at 7:52 AM
Head to Head Contrast: Calyxt (CLXT) vs. Evogene (EVGN)Head to Head Contrast: Calyxt (CLXT) vs. Evogene (EVGN)
www.americanbankingnews.com - December 13 at 5:12 AM
Calyxt and Farmer’s Business Network, Inc. Partner to Expand Grower Base for Calyxt’s Identity-Preserved High Oleic SoybeansCalyxt and Farmer’s Business Network, Inc. Partner to Expand Grower Base for Calyxt’s Identity-Preserved High Oleic Soybeans
finance.yahoo.com - December 12 at 6:25 PM
Financial Contrast: Calyxt (CLXT) versus Evogene (EVGN)Financial Contrast: Calyxt (CLXT) versus Evogene (EVGN)
www.americanbankingnews.com - December 12 at 3:24 AM
Evogene (EVGN) and Calyxt (CLXT) Critical SurveyEvogene (EVGN) and Calyxt (CLXT) Critical Survey
www.americanbankingnews.com - December 11 at 7:16 PM
Head to Head Contrast: Evogene (EVGN) vs. Calyxt (CLXT)Head to Head Contrast: Evogene (EVGN) vs. Calyxt (CLXT)
www.americanbankingnews.com - December 11 at 7:16 PM
Evogene (EVGN) and Calyxt (CLXT) Critical ContrastEvogene (EVGN) and Calyxt (CLXT) Critical Contrast
www.americanbankingnews.com - December 10 at 3:30 PM
Analyzing Evogene (EVGN) & Calyxt (CLXT)Analyzing Evogene (EVGN) & Calyxt (CLXT)
www.americanbankingnews.com - December 9 at 7:18 PM
Head to Head Analysis: Evogene (EVGN) vs. Calyxt (CLXT)Head to Head Analysis: Evogene (EVGN) vs. Calyxt (CLXT)
www.americanbankingnews.com - December 9 at 3:14 AM
Zacks: Calyxt, Inc. (CLXT) Receives Average Rating of "Buy" from AnalystsZacks: Calyxt, Inc. (CLXT) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - December 8 at 8:06 AM
Calyxt (CLXT) vs. Evogene (EVGN) Financial ContrastCalyxt (CLXT) vs. Evogene (EVGN) Financial Contrast
www.americanbankingnews.com - December 6 at 3:08 PM
Evogene (EVGN) vs. Calyxt (CLXT) Financial AnalysisEvogene (EVGN) vs. Calyxt (CLXT) Financial Analysis
www.americanbankingnews.com - December 4 at 7:39 PM
Evogene (EVGN) versus Calyxt (CLXT) Critical SurveyEvogene (EVGN) versus Calyxt (CLXT) Critical Survey
www.americanbankingnews.com - December 3 at 11:42 AM
Calyxt (CLXT) vs. Evogene (EVGN) Critical ComparisonCalyxt (CLXT) vs. Evogene (EVGN) Critical Comparison
www.americanbankingnews.com - December 3 at 11:42 AM
Head-To-Head Analysis: Evogene (EVGN) and Calyxt (CLXT)Head-To-Head Analysis: Evogene (EVGN) and Calyxt (CLXT)
www.americanbankingnews.com - December 2 at 1:08 PM
Financial Comparison: Calyxt (CLXT) vs. Evogene (EVGN)Financial Comparison: Calyxt (CLXT) vs. Evogene (EVGN)
www.americanbankingnews.com - December 2 at 1:06 PM
Head-To-Head Survey: Calyxt (CLXT) & Evogene (EVGN)Head-To-Head Survey: Calyxt (CLXT) & Evogene (EVGN)
www.americanbankingnews.com - November 30 at 9:58 PM
Financial Analysis: Evogene (EVGN) vs. Calyxt (CLXT)Financial Analysis: Evogene (EVGN) vs. Calyxt (CLXT)
www.americanbankingnews.com - November 30 at 11:18 AM
Calyxt (CLXT) Upgraded at Zacks Investment ResearchCalyxt (CLXT) Upgraded at Zacks Investment Research
www.americanbankingnews.com - November 28 at 7:50 PM
Critical Contrast: Evogene (EVGN) versus Calyxt (CLXT)Critical Contrast: Evogene (EVGN) versus Calyxt (CLXT)
www.americanbankingnews.com - November 27 at 5:28 AM
Financial Analysis: Evogene (EVGN) and Calyxt (CLXT)Financial Analysis: Evogene (EVGN) and Calyxt (CLXT)
www.americanbankingnews.com - November 26 at 4:14 AM
Reviewing Calyxt (CLXT) and Evogene (EVGN)Reviewing Calyxt (CLXT) and Evogene (EVGN)
www.americanbankingnews.com - November 25 at 8:14 AM
Critical Review: Evogene (EVGN) vs. Calyxt (CLXT)Critical Review: Evogene (EVGN) vs. Calyxt (CLXT)
www.americanbankingnews.com - November 25 at 5:12 AM
Critical Survey: Calyxt (CLXT) vs. Evogene (EVGN)Critical Survey: Calyxt (CLXT) vs. Evogene (EVGN)
www.americanbankingnews.com - November 24 at 8:24 AM
Financial Contrast: Evogene (EVGN) and Calyxt (CLXT)Financial Contrast: Evogene (EVGN) and Calyxt (CLXT)
www.americanbankingnews.com - November 24 at 8:16 AM
 Calyxt, Inc. (CLXT) Receives Average Recommendation of "Buy" from Analysts Calyxt, Inc. (CLXT) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 23 at 10:16 AM
Evogene (EVGN) versus Calyxt (CLXT) Head to Head ComparisonEvogene (EVGN) versus Calyxt (CLXT) Head to Head Comparison
www.americanbankingnews.com - November 21 at 7:33 PM
 Calyxt, Inc. (CLXT) Receives Average Rating of "Buy" from Brokerages Calyxt, Inc. (CLXT) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 19 at 11:34 AM
Financial Contrast: Calyxt (CLXT) and Evogene (EVGN)Financial Contrast: Calyxt (CLXT) and Evogene (EVGN)
www.americanbankingnews.com - November 19 at 8:42 AM
Comparing Evogene (EVGN) and Calyxt (CLXT)Comparing Evogene (EVGN) and Calyxt (CLXT)
www.americanbankingnews.com - November 18 at 4:22 AM
FY2017 EPS Estimates for Calyxt, Inc. Cut by Jefferies Group (CLXT)FY2017 EPS Estimates for Calyxt, Inc. Cut by Jefferies Group (CLXT)
www.americanbankingnews.com - November 17 at 9:22 PM
Calyxt, Inc. (CLXT) PT Lowered to $22.00Calyxt, Inc. (CLXT) PT Lowered to $22.00
www.americanbankingnews.com - November 16 at 7:47 PM
Critical Contrast: Evogene (EVGN) and Calyxt (CLXT)Critical Contrast: Evogene (EVGN) and Calyxt (CLXT)
www.americanbankingnews.com - November 16 at 8:36 AM
Calyxt Reports Financial Results for Third Quarter and First Nine Months of 2017Calyxt Reports Financial Results for Third Quarter and First Nine Months of 2017
finance.yahoo.com - November 13 at 10:38 PM
Calyxt, Inc. breached its 50 day moving average in a Bearish Manner : CLXT-US : November 8, 2017Calyxt, Inc. breached its 50 day moving average in a Bearish Manner : CLXT-US : November 8, 2017
finance.yahoo.com - November 8 at 9:16 PM
Calyxt, Inc. (CLXT) Expected to Earn Q3 2017 Earnings of ($0.20) Per ShareCalyxt, Inc. (CLXT) Expected to Earn Q3 2017 Earnings of ($0.20) Per Share
www.americanbankingnews.com - November 6 at 1:22 AM
 Calyxt, Inc. (CLXT) Given Consensus Recommendation of "Buy" by Brokerages Calyxt, Inc. (CLXT) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - November 4 at 9:46 AM
CLXT Crosses Above Average Analyst TargetCLXT Crosses Above Average Analyst Target
www.thestreet.com - November 4 at 7:22 AM

SEC Filings

Calyxt (NASDAQ:CLXT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Calyxt (NASDAQ:CLXT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Calyxt (NASDAQ CLXT) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.